We recently found that survivin inhibitor YM155 sensitize NSCLC cells to EGFR-TKIs through autophagy induction mediated by downregulating survivin expression and the AKT/mTOR pathway 14. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.